Cronos Group Inc CRON
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.63
- Day Range
- $2.57–2.64
- 52-Week Range
- $1.85–3.41
- Bid/Ask
- $2.61 / $2.62
- Shares Outstanding
- 373.66M
- Market Cap
- $984.60M
- Volume/Avg
- 774,213 / 1M
Key Statistics
- Price/Earnings (Normalized)
- 25.32
- Price/Sales
- 6.43
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.97%
Company Profile
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 610
- Website
- https://www.thecronosgroup.com
Valuation
|
Metric
|
CRON
|
|---|---|
Price/Earnings (Normalized) | 25.32 |
Price/Book Value | 0.94 |
Price/Sales | 6.43 |
Price/Cash Flow | 17.54 |
Price/Earnings
CRON
Financial Strength
|
Metric
|
CRON
|
|---|---|
Quick Ratio | 20.61 |
Current Ratio | 21.87 |
Interest Coverage | — |
Quick Ratio
CRON
Profitability
|
Metric
|
CRON
|
|---|---|
Return on Assets (Normalized) | 3.10% |
Return on Equity (Normalized) | 3.38% |
Return on Invested Capital (Normalized) | 0.28% |
Return on Assets
CRON
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| Svqcvtzvf | Jbxvly | $67B | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Gwfqzmmb | Nbjsd | $40B | |||
| Haleon PLC ADR
HLN
| Zprlrkzvj | Jnd | $40B | |||
| Zoetis Inc Class A
ZTS
| Gjrswdynm | Ryywl | $33B | |||
| Viatris Inc
VTRS
| Pqtbshgn | Jqky | $19B | |||
| Elanco Animal Health Inc
ELAN
| Zbkz | Xtj | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Zrpxrkf | Xnpmx | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| Dyscxxk | Tyjw | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| Kkwbfgbl | Rhnbbd | $2B | |||
| Perrigo Co PLC
PRGO
| Ljsxhqtz | Zgxyq | $2B |
United States